The potential role of T-cell metabolism-related molecules in chronic neuropathic pain after nerve injury: a narrative review

Neuropathic pain is a common type of chronic pain, primarily caused by peripheral nerve injury. Different T-cell subtypes play various roles in neuropathic pain caused by peripheral nerve damage. Peripheral nerve damage can lead to co-infiltration of neurons and other inflammatory cells, thereby altering the cellular microenvironment and affecting cellular metabolism. By elaborating on the above, we first relate chronic pain to T-cell energy metabolism. Then we summarize the molecules that have affected T-cell energy metabolism in the past five years and divide them into two categories. The first category could play a role in neuropathic pain, and we explain their roles in T-cell function and chronic pain, respectively. The second category has not yet been involved in neuropathic pain, and we focus on how they affect T-cell function by influencing T-cell metabolism. By discussing the above content, this review provides a reference for studying the direct relationship between chronic pain and T-cell metabolism and searching for potential therapeutic targets for the treatment of chronic pain on the level of T-cell energy metabolism.

[1]  Yimei Du,et al.  Inhibition of PGK1 attenuates autoimmune myocarditis by reprogramming CD4+ T cells metabolism. , 2023, Cardiovascular research.

[2]  H. Lorenz,et al.  Reduction of Proinflammatory Effector Functions Through Remodeling of Fatty Acid Metabolism in CD8+ T Cells From Rheumatoid Arthritis Patients , 2022, medRxiv.

[3]  L. M. Arruda,et al.  Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice , 2022, The Journal of clinical investigation.

[4]  Jiannan Zhang,et al.  IRG1/itaconate increases IL-10 release to alleviate mechanical and thermal hypersensitivity in mice after nerve injury , 2022, Frontiers in Immunology.

[5]  Mingfei Zhang,et al.  Triptolide inhibits Th17 differentiation via controlling PKM2-mediated glycolysis in rheumatoid arthritis , 2022, Immunopharmacology and immunotoxicology.

[6]  C. Liang,et al.  HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP , 2022, Frontiers in Immunology.

[7]  Er-liang Kong,et al.  Glycometabolism Reprogramming of Glial Cells in Central Nervous System: Novel Target for Neuropathic Pain , 2022, Frontiers in Immunology.

[8]  Xiaoxiao Yu,et al.  The neuropeptide cortistatin attenuates Th17 cell response through inhibition of glycolysis via GHSR1. , 2022, International immunopharmacology.

[9]  Guannan Su,et al.  PD-1 Targeted Nanoparticles Inhibit Activated T Cells and Alleviate Autoimmunity via Suppression of Cellular Energy Metabolism Mediated by PKM2 , 2022, International journal of nanomedicine.

[10]  I. Takasaki,et al.  Spinal Astrocyte-Neuron Lactate Shuttle Contributes to the Pituitary Adenylate Cyclase-Activating Polypeptide/PAC1 Receptor-Induced Nociceptive Behaviors in Mice , 2021, Biomolecules.

[11]  Chaofu Ke,et al.  Application of Metabolomics to the Discovery of Biomarkers for Ischemic Stroke in the Murine Model: a Comparison with the Clinical Results , 2021, Molecular Neurobiology.

[12]  S. Cohn,et al.  GPR120 inhibits colitis through regulation of CD4+T cell IL-10 production. , 2021, Gastroenterology.

[13]  Xiangmei Yu,et al.  Electroacupuncture suppresses glucose metabolism and GLUT-3 expression in medial prefrontal cortical in rats with neuropathic pain , 2021, Biological research.

[14]  Han-bing Wang,et al.  Abnormal Insulin-like Growth Factor 1 Signaling Regulates Neuropathic Pain by Mediating the Mechanistic Target of Rapamycin-Related Autophagy and Neuroinflammation in Mice. , 2021, ACS chemical neuroscience.

[15]  A. Schousboe,et al.  Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration , 2021, Neuropharmacology.

[16]  E. González-Rey,et al.  The Neuropeptide Cortistatin Alleviates Neuropathic Pain in Experimental Models of Peripheral Nerve Injury , 2021, Pharmaceutics.

[17]  L. Zon,et al.  Mitochondrial function in development and disease , 2021, Disease models & mechanisms.

[18]  Jae-Hoon Chang,et al.  LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1 , 2021, Journal of Molecular Medicine.

[19]  Jiyang Cai,et al.  IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells , 2021, Immunology.

[20]  M. Macias,et al.  Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease , 2021, Nature Communications.

[21]  R. Fischer,et al.  Role of Peripheral Immune Cells for Development and Recovery of Chronic Pain , 2021, Frontiers in Immunology.

[22]  A. Kavelaars,et al.  T Cells as Guardians of Pain Resolution. , 2021, Trends in molecular medicine.

[23]  D. DeGracia,et al.  Phosphoenolpyruvate Carboxykinase (PCK) in the Brain Gluconeogenic Pathway Contributes to Oxidative and Lactic Injury After Stroke , 2021, Molecular Neurobiology.

[24]  C. Svensson,et al.  The Neuroimmunology of Chronic Pain: From Rodents to Humans , 2020, The Journal of Neuroscience.

[25]  Xianxun Liu,et al.  Different expression of lipid metabolism-related genes in Shandong black cattle and Luxi cattle based on transcriptome analysis , 2020, Scientific Reports.

[26]  D. Pinho,et al.  Neuroinflammation, oxidative stress and their interplay in neuropathic pain: focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies. , 2020, Pharmacological research.

[27]  C. Taylor,et al.  Regulation of glycolysis by the hypoxia‐inducible factor (HIF): implications for cellular physiology , 2020, The Journal of physiology.

[28]  D. Murphy,et al.  Peripheral neuropathic pain. , 2020, NeuroRehabilitation.

[29]  N. Calcutt Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms? , 2020, Pain.

[30]  G. Brook,et al.  Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic pain. , 2020, Pharmacological research.

[31]  Shiyu Lin,et al.  Critical Role of AdipoR1 in Regulating Th17 Cell Differentiation Through Modulation of HIF-1α-Dependent Glycolysis , 2020, Frontiers in Immunology.

[32]  W. Maixner,et al.  Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain , 2020, Neurotherapeutics.

[33]  T. Jensen,et al.  Neuropathic pain: From mechanisms to treatment. , 2020, Physiological reviews.

[34]  Hong Jin,et al.  T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus , 2020, Frontiers in Immunology.

[35]  Shuai Jiang Tetrameric PKM2 Activation Curbs CD4+ T Cell Overactivation , 2020, Trends in Endocrinology & Metabolism.

[36]  R. D. Hatton,et al.  Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity. , 2020, Immunity.

[37]  Bing-Xun Wang,et al.  Exosome Derived from Coronary Serum of Patients with Myocardial Infarction Promotes Angiogenesis Through the miRNA-143/IGF-IR Pathway , 2020, International journal of nanomedicine.

[38]  D. Guan,et al.  Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions , 2020, Frontiers in Immunology.

[39]  Junying Yuan,et al.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke , 2020, Proceedings of the National Academy of Sciences.

[40]  A. Sharabi,et al.  T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy , 2020, Nature Reviews Rheumatology.

[41]  K. Iwata,et al.  Increase in IGF-1 Expression in the Injured Infraorbital Nerve and Possible Implications for Orofacial Neuropathic Pain , 2019, International journal of molecular sciences.

[42]  Liangcong Hu,et al.  IL‐10 induces MC3T3‐E1 cells differentiation towards osteoblastic fate in murine model , 2019, Journal of cellular and molecular medicine.

[43]  K. Mills,et al.  Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity , 2019, Cell metabolism.

[44]  T. Coderre,et al.  The emergence of animal models of chronic pain and logistical and methodological issues concerning their use , 2019, Journal of Neural Transmission.

[45]  B. Jiang,et al.  PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1. , 2019, Molecular cell.

[46]  G. Tsokos,et al.  Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus‐like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis , 2019, Arthritis & rheumatology.

[47]  A. Hoerauf,et al.  Adiponectin Limits IFN-γ and IL-17 Producing CD4 T Cells in Obesity by Restraining Cell Intrinsic Glycolysis , 2019, Front. Immunol..

[48]  Jia Liu,et al.  TLR2 Stimulation Increases Cellular Metabolism in CD8+ T Cells and Thereby Enhances CD8+ T Cell Activation, Function, and Antiviral Activity , 2019, The Journal of Immunology.

[49]  Jun Shen,et al.  The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta‐analysis of randomized controlled trials , 2019, Brain and behavior.

[50]  A. Kavelaars,et al.  T Cells as an Emerging Target for Chronic Pain Therapy , 2019, Front. Mol. Neurosci..

[51]  Sung Hoon Baik,et al.  A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease. , 2019, Cell metabolism.

[52]  G. Tsokos,et al.  Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation. , 2019, JCI insight.

[53]  Martina Kunkl,et al.  CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis , 2019, Cells.

[54]  Xiang‐Dong Wang,et al.  Effects of 1,8-cineole on neuropathic pain mediated by P2X2 receptor in the spinal cord dorsal horn , 2019, Scientific Reports.

[55]  K. Furukawa,et al.  Calcium/calmodulin-dependent protein kinase 4 promotes GLUT1-dependent glycolysis in systemic lupus erythematosus. , 2018 .

[56]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[57]  B. Moran,et al.  Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis , 2019, Front. Immunol..

[58]  M. Ohsawa,et al.  Astrocyte‐neuron lactate shuttle sensitizes nociceptive transmission in the spinal cord , 2018, Glia.

[59]  D. Sabatini,et al.  DEPTOR modulates activation responses in CD4+ T cells and enhances immunoregulation following transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[60]  K. Takenaka,et al.  Reinforce the antitumor activity of CD8+ T cells via glutamine restriction , 2018, Cancer science.

[61]  S. Pluchino,et al.  Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis. , 2018, Trends in molecular medicine.

[62]  Evangelia Karyka,et al.  Loss of IGF1R in Human Astrocytes Alters Complex I Activity and Support for Neurons , 2018, Neuroscience.

[63]  G. Tsokos,et al.  Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation , 2018, Proceedings of the National Academy of Sciences.

[64]  W. Maixner,et al.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. , 2018, Anesthesiology.

[65]  F. Paul,et al.  Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders , 2018, Multiple sclerosis journal - experimental, translational and clinical.

[66]  E. Hanse,et al.  The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells , 2018, Nature.

[67]  L. Sun,et al.  Adiponectin regulates thermal nociception in a mouse model of neuropathic pain , 2018, British journal of anaesthesia.

[68]  Weiwei Wang,et al.  Transcriptome analysis of adipose tissues from two fat-tailed sheep breeds reveals key genes involved in fat deposition , 2018, BMC Genomics.

[69]  Qingbo Xu,et al.  PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis , 2018, Journal of Molecular Medicine.

[70]  You-quan Ding,et al.  CD4+ αβ T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries , 2018, Journal of Neuroinflammation.

[71]  Xiaojuan Liu,et al.  PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord , 2018, The Journal of Headache and Pain.

[72]  C. Sommer,et al.  Inflammation in the pathophysiology of neuropathic pain , 2017, Pain.

[73]  L. Galluzzi,et al.  The spectrum of T cell metabolism in health and disease , 2017, Nature Reviews Immunology.

[74]  Jun-Ming Zhang,et al.  Inflammatory Changes in Paravertebral Sympathetic Ganglia in Two Rat Pain Models , 2018, Neuroscience Bulletin.

[75]  R. Liu,et al.  Berberine ameliorates collagen‐induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut , 2017, The FEBS journal.

[76]  F. Di Virgilio,et al.  The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.

[77]  D. Wallace,et al.  Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. , 2017, Cell metabolism.

[78]  Nicole E. Burma,et al.  Animal models of chronic pain: Advances and challenges for clinical translation , 2017, Journal of neuroscience research.

[79]  J. Rathmell,et al.  Dysfunctional T cell metabolism in the tumor microenvironment. , 2017, Cytokine & growth factor reviews.

[80]  S. Jain,et al.  Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction , 2017, International journal of molecular sciences.

[81]  R. Freeman,et al.  Neuropathic pain , 1999, The Lancet.

[82]  S. Maier,et al.  Nitroxidative Signaling Mechanisms in Pathological Pain , 2016, Trends in Neurosciences.

[83]  T. Sparwasser,et al.  Metabolic pathways in T cell activation and lineage differentiation. , 2016, Seminars in immunology.

[84]  S. Azad,et al.  Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain , 2016, Journal of Neuroinflammation.

[85]  Long-Jun Wu,et al.  Interleukin-1β overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents , 2016, Molecular pain.

[86]  Y. Tsai,et al.  Hypoxia inducible factor‐1α inhibition produced anti‐allodynia effect and suppressed inflammatory cytokine production in early stage of mouse complex regional pain syndrome model , 2016, Clinical and experimental pharmacology & physiology.

[87]  D. Poulsen,et al.  GLT1 overexpression reverses established neuropathic pain‐related behavior and attenuates chronic dorsal horn neuron activation following cervical spinal cord injury , 2016, Glia.

[88]  T. Eleftheriadis,et al.  Indoleamine 2,3‑dioxygenase downregulates T‑cell receptor complex ζ‑chain and c‑Myc, and reduces proliferation, lactate dehydrogenase levels and mitochondrial glutaminase in human T‑cells. , 2016, Molecular medicine reports.

[89]  Harald H. H. W. Schmidt,et al.  Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications , 2015, Antioxidants & redox signaling.

[90]  A. Strongin,et al.  The alternatively spliced fibronectin CS1 isoform regulates IL-17A levels and mechanical allodynia after peripheral nerve injury , 2015, Journal of Neuroinflammation.

[91]  Ningli Li,et al.  Adiponectin exacerbates collagen-induced arthritis via enhancing Th17 response and prompting RANKL expression , 2015, Scientific Reports.

[92]  R. Spengler,et al.  The hippocampus and TNF: Common links between chronic pain and depression , 2015, Neuroscience & Biobehavioral Reviews.

[93]  N. Kiguchi,et al.  Macrophage-T Cell Interactions Mediate Neuropathic Pain through the Glucocorticoid-induced Tumor Necrosis Factor Ligand System* , 2015, The Journal of Biological Chemistry.

[94]  S. Challa Surgical animal models of neuropathic pain: Pros and Cons , 2015, The International journal of neuroscience.

[95]  M. Ferracin,et al.  The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma , 2015, Oncogene.

[96]  J. Locasale,et al.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. , 2015, The Journal of clinical investigation.

[97]  William J. Israelsen,et al.  Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. , 2014, Molecular cell.

[98]  Michael B H Smith Pros and cons …. , 2014, Evidence-based child health : a Cochrane review journal.

[99]  M. Heil,et al.  Danger signals – damaged-self recognition across the tree of life , 2014, Front. Plant Sci..

[100]  P. Stemkowski,et al.  The Tao of IGF-1: Insulin-Like Growth Factor Receptor Activation Increases Pain by Enhancing T-Type Calcium Channel Activity , 2014, Science Signaling.

[101]  R. Brandes,et al.  Nox2-dependent signaling between macrophages and sensory neurons contributes to neuropathic pain hypersensitivity , 2014, PAIN®.

[102]  G. Bennett,et al.  Mitotoxicity in distal symmetrical sensory peripheral neuropathies , 2014, Nature Reviews Neurology.

[103]  L. Stokes,et al.  The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease , 2014, Pharmacological Reviews.

[104]  G. Bennett,et al.  Mitotoxicity in distal symmetrical sensory peripheral neuropathies , 2014, Nature Reviews Neurology.

[105]  E. McLachlan,et al.  Inflammation in dorsal root ganglia after peripheral nerve injury: Effects of the sympathetic innervation , 2014, Autonomic Neuroscience.

[106]  M. Cusick,et al.  Targeting Insulin-Like Growth Factor 1 Leads to Amelioration of Inflammatory Demyelinating Disease , 2014, PloS one.

[107]  Yu Kyeong Kim,et al.  Transcranial Direct Current Stimulation to Lessen Neuropathic Pain After Spinal Cord Injury , 2014, Neurorehabilitation and neural repair.

[108]  L. Lecea,et al.  Cortistatin attenuates inflammatory pain via spinal and peripheral actions , 2014, Neurobiology of Disease.

[109]  C. Yen,et al.  Gabapentin reverses central hypersensitivity and suppresses medial prefrontal cortical glucose metabolism in rats with neuropathic pain , 2014, Molecular pain.

[110]  D. Guertin,et al.  T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. , 2013, Immunity.

[111]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[112]  Peter Vogel,et al.  mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.

[113]  Wang Zan,et al.  Identification of Adiponectin Receptor Agonist Utilizing a Fluorescence Polarization Based High Throughput Assay , 2013, PloS one.

[114]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[115]  David K. Finlay,et al.  AMPKα1: A glucose sensor that controls CD8 T-cell memory , 2013, European journal of immunology.

[116]  Songfang Wu,et al.  Dual roles of PKM2 in cancer metabolism. , 2013, Acta biochimica et biophysica Sinica.

[117]  Gila Moalem-Taylor,et al.  Regulatory T cells attenuate neuropathic pain following peripheral nerve injury and experimental autoimmune neuritis , 2012, PAIN®.

[118]  F. Di Virgilio,et al.  The P2X7 receptor is a key modulator of aerobic glycolysis , 2012, Cell Death and Disease.

[119]  G. V. D. van der Windt,et al.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.

[120]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[121]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[122]  T. Yaksh,et al.  A brief comparison of the pathophysiology of inflammatory versus neuropathic pain , 2011, Current opinion in anaesthesiology.

[123]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[124]  S. Mazurek Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. , 2011, The international journal of biochemistry & cell biology.

[125]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[126]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[127]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[128]  D. Weinberger,et al.  Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior , 2011, Molecular Brain.

[129]  Gila Moalem-Taylor,et al.  Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. , 2011, The journal of pain : official journal of the American Pain Society.

[130]  T. Horvath,et al.  An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. , 2010, Immunity.

[131]  Jason W. Locasale,et al.  Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells , 2010, Science.

[132]  Erika L. Pearce Metabolism in T cell activation and differentiation. , 2010, Current opinion in immunology.

[133]  J. Rathmell,et al.  IL-7 Is Essential for Homeostatic Control of T Cell Metabolism In Vivo , 2010, The Journal of Immunology.

[134]  Maria Fitzgerald,et al.  T-Cell Infiltration and Signaling in the Adult Dorsal Spinal Cord Is a Major Contributor to Neuropathic Pain-Like Hypersensitivity , 2009, The Journal of Neuroscience.

[135]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[136]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[137]  H. Shimoyama,et al.  IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic pain , 2009, Proceedings of the National Academy of Sciences.

[138]  M. Lopes-Virella,et al.  Lactate Boosts TLR4 Signaling and NF-κB Pathway-Mediated Gene Transcription in Macrophages via Monocarboxylate Transporters and MD-2 Up-Regulation1 , 2009, The Journal of Immunology.

[139]  J. Rathmell,et al.  Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.

[140]  J. Deleo,et al.  CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic pain , 2008, European journal of immunology.

[141]  C. Chapman,et al.  Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. , 2008, The journal of pain : official journal of the American Pain Society.

[142]  D. Hardie,et al.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.

[143]  Russell G. Jones,et al.  Revving the engine: signal transduction fuels T cell activation. , 2007, Immunity.

[144]  C. Sommer,et al.  Differential expression of cytokines in painful and painless neuropathies , 2007, Neurology.

[145]  S. Meuth,et al.  T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression , 2006, Experimental Neurology.

[146]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[147]  C. Woolf,et al.  Bradykinin and peripheral sensitization , 2006, Biological chemistry.

[148]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[149]  F. Di Virgilio,et al.  Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. , 2005, Molecular biology of the cell.

[150]  P. Anand,et al.  Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.

[151]  G. Moalem,et al.  T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats , 2004, Neuroscience.

[152]  최용규,et al.  Hypersensitivity , 2020, Definitions.

[153]  C. Lamendola,et al.  Discrimination between obesity and insulin resistance in the relationship with adiponectin. , 2004, Diabetes.

[154]  E. McLachlan,et al.  Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat , 2002, Neuroscience.

[155]  L. Sorkin,et al.  Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat , 2000, Journal of the peripheral nervous system : JPNS.

[156]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[157]  C. Woolf Evidence for a central component of post-injury pain hypersensitivity , 1983, Nature.